(R)-6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-6-ol, 95+%, 1g

6-O-benzyl 3-O-ethyl 2-amino-5,7-dihydro-4H-thieno[2,3-c]pyridine-3,6-dicarboxylate, 97%, 250mg

(bpy)Cu(CF3)3, 97%, 100mg

(2E)-1-(4-ethylphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

(4-((2-Chlorophenyl)carbamoyl)phenyl)boronic acid, 98%, 5g

1-(2-Chloroethyl)-1H-1,2,4-triazole, 95.0%, 1g

Ethyl 3-aminoquinoline-2-carboxylate, 97%, 1g

METHYL 4-HYDROXY-2-NITROBENZOATE, 95.0%, 1g

1,3-Propylenediisothiocyanate, 98.0%, 250mg

Mesityleneacetic Acid>98.0%(T)(GC)5g

(S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride, 95.0%, 1g

Colonna capillare per GC ROTI®Cap-1, 25 m, 0.25 mm, 1.00 µm, 1 Pezzo(i)

3-Azidopropylamine>95.0%(GC)(T)100mg